These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28708433)

  • 1. Physical Health Outcomes in Preschoolers with Prior Authorization for Antipsychotics.
    Wei YJ; Liu X; Rao N; McPherson M; Jones MB; Bussing R; Winterstein AG
    J Child Adolesc Psychopharmacol; 2017 Nov; 27(9):833-839. PubMed ID: 28708433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of tardive dyskinesia and tardive dystonia in African Caribbean patients on long-term antipsychotic treatment: the Curaçao extrapyramidal syndromes study V.
    van Harten PN; Hoek HW; Matroos GE; van Os J
    J Clin Psychiatry; 2006 Dec; 67(12):1920-7. PubMed ID: 17194270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of movement disorders in adolescent patients with schizophrenia and in relationship to predominantly atypical antipsychotic treatment.
    Gebhardt S; Härtling F; Hanke M; Mittendorf M; Theisen FM; Wolf-Ostermann K; Grant P; Martin M; Fleischhaker C; Schulz E; Remschmidt H
    Eur Child Adolesc Psychiatry; 2006 Oct; 15(7):371-82. PubMed ID: 16648965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inter-relationships of tardive dyskinesia, parkinsonism, akathisia and tardive dystonia: the Curaçao Extrapyramidal Syndromes Study II.
    van Harten PN; Hoek HW; Matroos GE; Koeter M; Kahn RS
    Schizophr Res; 1997 Aug; 26(2-3):235-42. PubMed ID: 9323356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of EPS and tardive dyskinesia in clinical trials. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998; 59 Suppl 12():23-7. PubMed ID: 9766616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrapyramidal symptoms with atypical antipsychotics : incidence, prevention and management.
    Pierre JM
    Drug Saf; 2005; 28(3):191-208. PubMed ID: 15733025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Movement disorders associated with neuroleptic treatment.
    Wirshing WC
    J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Relationship Between Early Haloperidol Response and Associated Extrapyramidal Side Effects.
    Rasmussen SA; Rosebush PI; Mazurek MF
    J Clin Psychopharmacol; 2017 Feb; 37(1):8-12. PubMed ID: 28027109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-Generation Antipsychotic Prescribing Patterns for Pediatric Patients Enrolled in West Virginia Medicaid.
    Melvin KE; Hart JC; Sorvig RD
    Psychiatr Serv; 2017 Oct; 68(10):1061-1067. PubMed ID: 28566023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early diagnoses and psychotherapeutic medication treatment experiences of a cohort of children under 6 years old who received antipsychotic treatment in Florida's Medicaid program.
    Constantine RJ; Tandon R; McPherson M; Andel R
    J Child Adolesc Psychopharmacol; 2011 Feb; 21(1):79-84. PubMed ID: 21288122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Movement disorders in patients with schizophrenia and a history of substance abuse.
    Hansen LK; Nausheen B; Hart D; Kingdon D
    Hum Psychopharmacol; 2013 Mar; 28(2):192-7. PubMed ID: 23532750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the Florida Medicaid prior-authorization program on use of antipsychotics by children under age six.
    Constantine R; Bengtson MA; Murphy T; McPherson M; Andel R; Jones ME; Donaldson-Guenther C
    Psychiatr Serv; 2012 Dec; 63(12):1257-60. PubMed ID: 23203363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes, tardive dyskinesia, parkinsonism, and akathisia in schizophrenia: a retrospective study applying 1998 diabetes health care guidelines to antipsychotic use.
    Lévy E; Margolese HC; Annable L; Chouinard G
    Can J Psychiatry; 2004 Jun; 49(6):398-402. PubMed ID: 15283536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of antipsychotic treatment on tardive dyskinesia: a 6-month evaluation of patients from the European Schizophrenia Outpatient Health Outcomes (SOHO) Study.
    Tenback DE; van Harten PN; Slooff CJ; Belger MA; van Os J;
    J Clin Psychiatry; 2005 Sep; 66(9):1130-3. PubMed ID: 16187770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of tardive dyskinesia in the elderly: rates and risk factors.
    Woerner MG; Alvir JM; Saltz BL; Lieberman JA; Kane JM
    Am J Psychiatry; 1998 Nov; 155(11):1521-8. PubMed ID: 9812112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients.
    Richardson MA; Haugland G; Craig TJ
    Am J Psychiatry; 1991 Oct; 148(10):1322-8. PubMed ID: 1680296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and persistence of tardive dyskinesia and extrapyramidal symptoms in schizophrenia.
    Tenback DE; van Harten PN; Slooff CJ; van Os J
    J Psychopharmacol; 2010 Jul; 24(7):1031-5. PubMed ID: 19487321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relations between movement disorders and psychopathology under predominantly atypical antipsychotic treatment in adolescent patients with schizophrenia.
    Gebhardt S; Härtling F; Hanke M; Theisen FM; von Georgi R; Grant P; Mittendorf M; Martin M; Fleischhaker C; Schulz E; Remschmidt H
    Eur Child Adolesc Psychiatry; 2008 Feb; 17(1):44-53. PubMed ID: 17876506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of newer antipsychotics on extrapyramidal function.
    Tarsy D; Baldessarini RJ; Tarazi FI
    CNS Drugs; 2002; 16(1):23-45. PubMed ID: 11772117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations between in vitro affinity of antipsychotics to various central neurotransmitter receptors and clinical incidence of their adverse drug reactions.
    Sekine Y; Rikihisa T; Ogata H; Echizen H; Arakawa Y
    Eur J Clin Pharmacol; 1999 Oct; 55(8):583-7. PubMed ID: 10541776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.